← Back to Screener
Cingulate Inc. Warrants (CINGW)
Price$0.02
Favorite Metrics
Price vs S&P 500 (26W)-74.17%
Price vs S&P 500 (4W)-57.76%
All Metrics
Price vs S&P 500 (YTD)-66.85%
10-Day Avg Trading Volume0.04M
3-Month Avg Trading Volume0.04M
52-Week High$0.17
26-Week Price Return-65.42%
13-Week Price Return-64.73%
3-Month Return Std Dev259.26%
Year-to-Date Return-64.53%
5-Day Price Return-22.40%
Month-to-Date Return-35.97%
Price vs S&P 500 (13W)-67.59%
Beta0.15x
52-Week Low$0.02
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CINGWCingulate Inc. Warrants | — | — | — | — | $0.02 |
LLYEli Lilly & Co. | 13.44x | 44.70% | 83.04% | 27.59% | $927.03 |
JNJJohnson & Johnson | 5.85x | 7.87% | 67.95% | 14.90% | $234.18 |
ABBVABBVIE INC. | 6.03x | 8.57% | 71.62% | -2.88% | $208.38 |
MRKMerck & Co., Inc. | 4.53x | 1.31% | 78.55% | 21.23% | $119.07 |
AZNAstraZeneca PLC | 5.30x | 8.63% | 81.31% | 21.88% | $204.80 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $151.97 |
NVONovo-Nordisk A/S | 3.70x | 6.43% | 80.98% | 20.66% | $40.52 |
ABTAbbott Laboratories | 3.74x | 6.59% | 56.50% | 8.20% | $96.81 |
PFEPfizer Inc. | 2.51x | -1.64% | 75.81% | -3.51% | $27.56 |
BMYBristol-Myers Squibb Co. | 2.55x | -0.22% | 72.63% | — | $60.17 |
About
Cingulate Inc is a clinical-stage biopharmaceutical company developing treatments for ADHD and anxiety using its proprietary precision timed-release (PTR) drug delivery platform, which reduces dosing frequency. The PTR technology addresses the unmet need for improved patient outcomes and medication adherence in conditions requiring frequent daily dosing. The company is also evaluating additional therapeutic indications to expand its pipeline.